[REVISION HISTORY]
Global trends and scrutiny in neurodivergence diagnoses
Updated 11 times since CLSTR started tracking revisions of this situation.
What changed
2026-10-17 15:02 UTC → 2026-10-19 06:56 UTC ·
added
removed
Global trends show a significant rise in neurodivergence diagnoses, including Autism Spectrum Disorder (ASD) and ADHD. While experts suggest this reflects improved diagnostic criteria and societal understanding, recent data highlights the scale of this increase. In Denmark, diagnoses for both conditions tripled between 2000 and 2024. Recent data from Brazil shows approximately 2.4 million people have self-declared autism, while CDC data in the United States indicates prevalence has reached one in every 36 children. Experts suggest these figures reflect improved diagnostic criteria, such as the 2013 DSM-5 unification, rather than a simple explosion of cases. However, psychologist Fernanda Martins warns against the risks of social media content leading to premature self-identification, noting that possessing a single trait does not automatically constitute a diagnosis. Gender disparities in ADHD identification remain a critical focus. In Bavaria, Germany, a report from DAK Bayern found that 1.8 percent of young people received a first-time ADHD diagnosis in 2024, a 17 percent annual increase. In this region, boys were diagnosed nearly twice as often as girls, a trend that contradicts national German statistics. Medical experts, including Inga Schumann, suggest a need to better identify the “quieter” variants of ADHD in girls, who are currently treated with medication less frequently than boys. In the Netherlands, a national survey led by pediatricians Sultan Duyar and Rob Pereira is investigating why ADHD is diagnosed two to three times more frequently in boys than girls. The initiative aims to understand how symptoms manifest in females aged 6 to 17 to ensure timely support. Recent expert guidance emphasizes that clinical assessment must consider the duration, frequency, and intensity of behaviors, as well as the level of impairment experienced. Prof. Eva Möhler notes that “neurodivergence” is a social movement term rather than a medical diagnosis, highlighting both cognitive challenges and strengths.
Versions
- 2026-10-19 06:56 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-10-17 15:02 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-28 21:55 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-28 08:51 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-24 01:35 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-23 09:34 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-22 07:44 UTC Global trends and scrutiny in neurodivergence diagnoses
- 2026-09-21 01:06 UTC Global trends in neurodivergence diagnoses
- 2026-09-17 04:49 UTC Global trends in neurodivergence diagnoses
- 2026-09-16 10:52 UTC Global trends in neurodivergence diagnoses
- 2026-09-10 02:11 UTC Global trends in neurodivergence diagnoses
- 2026-08-31 18:09 UTC Global trends in neurodivergence diagnoses
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.